Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P279 | DOI: 10.1530/endoabs.110.P279

ECEESPE2025 Poster Presentations Bone and Mineral Metabolism (112 abstracts)

Hospitalizations in people with rare bone diseases across age groups: a population-based cohort study in switzerland

Pascal Gaechter1, 2, Fahim Ebrahimi3, 4, Christian Meier5, Emanuel Christ5, Alexander Kutz6, 7 & Gabor Szinnai1, 2


1University Children’s Hospital Basel, Pediatric Endocrinology and Diabetology, Basel, Switzerland; 2University Hospital Basel, Department of Clinical Research, Basel, Switzerland; 3Clarunis, Department of Gastroenterology & Hepatology, University Digestive Health Care Center, Basel, Switzerland; 4Karolinska Institute, Medical Epidemiology and Biostatistics, Stockholm, Sweden; 5University Hospital Basel, Endocrinology, Diabetology and Metabolism, Basel, Switzerland; 6Kantonsspital Aarau, Division of General Internal and Emergency Medicine, University Department of Medicine, Aarau, Switzerland; 7Brigham and Women’s Hospital and Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Boston, MA, United States


JOINT1326

Introduction: Rare bone diseases pose challenges for both affected people and healthcare systems, necessitating optimized multidisciplinary and individualized care. However, comprehensive data on age-specific hospitalization rates, associated clinical conditions, causes of hospitalization, and in-hospital outcomes across different age groups remain limited.

Design and Methods: This is a population-based nationwide cohort study using administrative claims data from Switzerland between January 1, 2012, and December 31, 2021. We identified individuals across all ages with a diagnosis of a rare bone disease: Achondroplasia, fibrous dysplasia (FD), fibrodysplasia ossificans progressiva (FOP), osteogenesis imperfecta (OI), pseudohypoparathyroidism, and X-linked familial hypophosphatemia (XLH). Incidence rates, main causes of hospitalization, and in-hospital outcomes were assessed and compared with those of the general population.

Results: Among 11, 103, 800 hospitalizations, 2, 878 involved individuals with at least one rare bone disease: 218 hospitalizations of people with achondroplasia, 436 with FD, 62 with FOD, 926 with OI, 87 with pseudohypoparathyroidism, 1, 148 with XLH, and one individual with both FD and pseudohypoparathoyroidism. Hospitalizations were disproportionately high in pediatric patients (ages 0-17 years) with achondroplasia (52. 1% vs. 7. 3% in the general population) and OI (41. 1% vs. 7. 3%). In contrast, most hospitalizations of people with XLH occured in adulthood (18-90 years), similar to the general population (95. 2% vs. 92. 7%). Locally estimated scatterplot smoothing (LOESS) plots highlight distinct hospitalization patterns across rare bone diseases, with fractures being a significantly more common cause, particularly in pediatric OI cases.

Conclusions: This study shows distinct age-specific hospitalization patterns across rare bone diseases, emphasizing the need for tailored management strategies. The findings highlight the importance of an age-inclusive approach to optimize care in this population.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches